This week’s #MondayBites dives into early positive lessons/takeaways from long-acting therapy, despite initial worries about missed appointments and injection tolerance.
🔗Watch the full lecture on the accredited e-learning module here: amededu.co/4a2NgTM
#IDSky #MedSky #HIVSky #LAART #LongActing
📣 Discover today’s programme at #ICASA2025 — happening at Booth 50!
We’re proud to highlight key moments of the day featuring the @medicinespatentpool.org team and partners.
lnkd.in/e7DTMEYc
#HIV #LongActing #GlobalHealth #AccessToMedicines #PublicHealth #EndingHIV #LeavingNoOneBehind
TI POTREBBE INTERESSARE: HIV, nuove conferme su terapie e profilassi long-acting ... LEGGI TUTTO #HIV #Terapie #Profilassi #LongActing #Salute
È ACCADUTO IERI: HIV, nuove conferme su terapie e profilassi long-acting ... LEGGI TUTTO #HIV #TerapieHIV #Profilassi #LongActing #Salute
HIV, nuove conferme su terapie e profilassi long-acting ... LEGGI TUTTO #HIV #Terapie #Profilassi #LongActing #PrevenzioneHIV
Aids, infettivologa Castagna: "Long-acting è opzione irrinunciabile in trattamento Hiv" ... LEGGI TUTTO #AIDS #HIV #LongActing #Salute #TrattamentoHIV
Liver cancer? #LongActing drugs? #Epidemiology? Drug resistance? Coinfections or multimorbidity? Share your findings at the 9th Central and Eastern European Meeting on #ViralHepatitis and #HIV 2025!
Abstracts open until Fri, 19 Sep
🔗 amededu.co/4fkiOWa
#CEEViralHepHIV #IDSky #MedSky #MedEd
Next stop: Amsterdam!
Counting down the days to the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs!
Topics: #pandemic preparedness, #druginteraction, #LongActing for #HCV, #CMVTherapy, and more!
🔗 amededu.co/4hTUPgN
#IDSky #MedSky #ANTIVIRALPK
#LongActing anti-infectives go far beyond injections.
This week’s #MondayBites, Dr. Charles Flexner shares insights from the 1st International Workshop on Long-Acting Anti-Infectives (LAAI) 2025.
🔗Dive into the full talk (plus the workshop materials): amededu.co/45KJWdu
#IDSky #MedSky #LAART #HIV
Excited to be at #IAS2025 tomorrow for our symposium, “How #LongActing Drugs Can Help End the #HIV Pandemic in Africa”!
⏲️ Tue, 15 Jul | 12:15 - 13:15
📍 Room MH1, Kigali Convention Center
Full program 👇 or visit: amededu.co/4la5WDP
No extra sign-up needed! @iasociety.bsky.social
#IASConference
#Throwback to the 1st International Workshop on Long-Acting Anti-Infectives (LAAI) 2025, held on 21–22 May in New Orleans, where we dove into how #LongActing formulations are reshaping approaches to treatment and prevention.
📽️ Videos and slides: amededu.co/4i4zcdX
#LAAIWS
💉 In the US, the Food and Drug Administration (FDA) have approved twice-yearly #longacting injections of lenacapavir for #HIV prevention.
In this article @celtliverpool.bsky.social's Prof. Andrew Owen explains what this means for people living with HIV.
👉 theconversation.com/us-approves-...
Colourful i-Base graphic. The main text reads: Combining injectable lenacapavir and cabotegravir-LA. Option for easier ART globally?. At the top is a URL: I hyphen base dot info. At the bottom it says, subscribe by email. A smaller, tilted square graphic on the right, reads: HTB news. 2025. HIV treatment, prevention, access, and more. The colours used in the image are three shades of dark blue, pink, dark magenta, lime green, dark orange, dark teal, dark green, lilac, light blue, mustard, teal, orange, dark blue, red, and white.
Potential #GlobalHealth option from combining #lenacapavir & #cabotegravir-LA:
i-base.info/htb/51095
A @jama.com article on how this new #HIVtreatment combination might help low- and middle-income countries more quickly.
#HIV #Antiretrovirals #LMICs #LongActing #EndAIDS2030
a person is reading the news on their tablet
Our Global News is #LongActing therapeutics news from other researchers.
Last week:
🦵an analgesic from Pacira BioSciences, a single dose lasts 2 years
💉 A single-injection multiple-dose vaccine from VitriVax.
If there's any news you've missed, catch up below:
www.liverpool.ac.uk/centre-of-ex...
i-Base graphic. The main text in red and dark blue, on a light blue blue background, reads: CROI 2025. Conference on retroviruses and opportunistic infections. Below, in white on a burnt orange background, text reads, San Francisco, California. 9th to 12th March. Next to this is a faint image of the Golden Gate Bridge. In the top left corner is a URL: I hyphen base dot info. In the top right corner is the CROI logo, a colourful illustration of HIV.
i-Base reports from this year’s #CROI2025 conference:
i-base.info/htb/50463
Highlights from the programme include:
- New compounds and combinations for #HIVtreatment
- Access to #PrEP
- #bNAbs and cure-related research
- Weight changes and #GLP1 agonists
#islatravir #lenacapavir #LongActing
Long-acting therapies: The future of infectious disease treatment?
Join the 1st International Workshop on Long-Acting Anti-Infectives (LAAI) 2025 to explore long-acting solutions for #HIV, #TB, and more!
📅 21-22 May
📍 New Orleans, LA, US
🔗 amededu.co/4i4zcdX
#LAAIWS #IDSky #MedSky #LongActing
i-Base graphic. Body text reads: Potential future ART options. HIV treatment taken every 2, 3, 4 and 6 months. I dash base dot info is in the top left corner of the image. Text on the right hand side reads, HTB news. 2025. HIV treatment, prevention, access, and more. At the bottom it says, subscribe by email.
Exciting new #HIV pipeline drugs presented at #HIVGlasgow2024:
i-base.info/htb/49783
Researchers are working on many new HIV combinations to expand #HIVtreatment options.
Including once-weekly oral meds and injectable meds every 2, 3, 4 and 6 months.
#HIVGlasgow #LongActing #Antiretrovirals
